ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 5000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 10000 iu / 0.6 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with chemotherapy. treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative erythropoietin deficiency* and are receiving anti-tumor therapy. * deficiency is defined as an

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 4000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 6000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 30000 iu / 0.6 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with chemotherapy . treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative erythropoietin deficiency and are receiving anti-tumor therapy. deficiency is defined as an i

ישראל - עברית - Ministry of Health

baxter healthcare distribution ltd., israel - arginine; calcium chloride dihydrate; glycine; histidine; isoleucine; l- alanine; leucine; lysine hydrochloride; magnesium chloride hexahydrate; methionine; phenylalanine; proline; serine; sodium (s) - lactate; sodium chloride; threonine; tryptophan; tyrosine; valine - תמיסה לדיאליזה פריטוניאלית - tyrosine 0.3 g/l; tryptophan 0.27 g/l; phenylalanine 0.57 g/l; threonine 0.646 g/l; serine 0.51 g/l; proline 0595 g/l; glycine 0.51 g/l; l- alanine 0.951 g/l; valine 1.393 g/l; methionine 0.85 g/l; isoleucine 0.85 g/l; leucine 1.02 g/l; histidine 0.714 g/l; arginine 1.071 g/l; sodium chloride 5.38 g/l; lysine hydrochloride 0.955 g/l; calcium chloride dihydrate 0.184 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium (s) - lactate 4.480 g/l - combinations of electrolytes - combinations of electrolytes - nutritional supplement for malnourished renal failure patients (albumin concentration lower then 35 g/liter) being maintained on peritoneal dialysis.

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - arginine; aspartic acid; disodium phosphate dodecahydrate; glutamine; glycine; histidine; isoleucine; l- alanine; leucine; lysine as acetate; magnesium chloride hexahydrate; methionine; phenylalanine; potassium acetate; proline; serine; sodium acetate trihydrate; threonine; tryptophan; tyrosine; valine - תמיסה לאינפוזיה - isoleucine 5.00 g/l; leucine 8.9 g/l; methionine 4.40 g/l; phenylalanine 4.70 g/l; threonine 4.20 g/l; tryptophan 1.60 g/l; valine 6.20 g/l; arginine 11.50 g/l; histidine 3.00 g/l; glycine 12.00 g/l; l- alanine 10.50 g/l; proline 5.50 g/l; aspartic acid 5.60 g/l; glutamine 7.20 g/l; serine 2.30 g/l; tyrosine 0.40 g/l; potassium acetate 2.453 g/l; sodium acetate trihydrate 2.858 g/l; magnesium chloride hexahydrate 0.508 g/l; lysine as acetate 8.56 g/l; disodium phosphate dodecahydrate 3.581 g/l - combinations

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - arginine; aspartic acid; glutamine; glycine; histidine; isoleucine; l- alanine; leucine; lysine as acetate; lysine as monohydrate; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine; valine - תמיסה לאינפוזיה - isoleucine 5.00 g/l; leucine 8.9 g/l; methionine 4.40 g/l; phenylalanine 4.70 g/l; threonine 4.20 g/l; tryptophan 1.60 g/l; valine 6.20 g/l; arginine 11.50 g/l; histidine 3.00 g/l; l- alanine 10.50 g/l; glycine 12.00 g/l; aspartic acid 5.60 g/l; glutamine 7.20 g/l; proline 5.50 g/l; serine 2.30 g/l; tyrosine 0.40 g/l; lysine as acetate 5.74 g/l; lysine as monohydrate 3.12 g/l - combinations

ישראל - עברית - Ministry of Health

remedix care ltd - alanine; arginine; aspartic acid; calcium chloride dihydrate; glucose monohydrate; glutamic acid; glycine; histidine; isoleucine; leucine; lysine; magnesium chloride; methionine; phenylalanine; potassium chloride; proline; serine; sodium acetate trihydrate; sodium glycerophosphate hydrate; soya bean oil refined + olive oil refined; threonine; tryptophan; tyrosine; valine - תחליב לאינפוזיה - alanine 9.16 g / 1 l; arginine 6.20 g / 1 l; aspartic acid 1.83 g / 1 l; glutamic acid 3.16 g / 1 l; glycine 4.39 g / 1 l; histidine 3.77 g / 1 l; isoleucine 3.16 g / 1 l; leucine 4.39 g / 1 l; lysine 4.98 g / 1 l; methionine 3.16 g / 1 l; phenylalanine 4.39 g / 1 l; proline 3.77 g / 1 l; serine 2.50 g / 1 l; threonine 3.16 g / 1 l; tryptophan 1.06 g / 1 l; tyrosine 0.16 g / 1 l; valine 4.05 g / 1 l; sodium acetate trihydrate 2.89 g / 1 l; potassium chloride 2.98 g / 1 l; magnesium chloride 1.12 g / 1 l; sodium glycerophosphate hydrate 4.78 g / 1 l; soya bean oil refined + olive oil refined 150 g / 1 l; calcium chloride dihydrate 0.74 g / 1 l; glucose monohydrate 206.25 g / 1 l - combinations - combinations - triomel is indicated for parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

ישראל - עברית - Ministry of Health

remedix care ltd - alanine; arginine; aspartic acid; calcium chloride dihydrate; glucose monohydrate; glutamic acid; glycine; histidine; isoleucine; leucine; lysine; magnesium chloride; methionine; phenylalanine; potassium chloride; proline; serine; sodium acetate trihydrate; sodium glycerophosphate hydrate; soya bean oil refined + olive oil refined; threonine; tryptophan; tyrosine; valine - תחליב לאינפוזיה - alanine 11.90 g / 1 l; arginine 8.06 g / 1 l; aspartic acid 2.38 g / 1 l; glutamic acid 4.11 g / 1 l; glycine 5.70 g / 1 l; histidine 4.91 g / 1 l; isoleucine 4.11 g / 1 l; leucine 5.70 g / 1 l; lysine 6.47 g / 1 l; methionine 4.11 g / 1 l; phenylalanine 5.70 g / 1 l; proline 4.91 g / 1 l; serine 3.25 g / 1 l; threonine 4.11 g / 1 l; tryptophan 1.37 g / 1 l; tyrosine 0.21 g / 1 l; valine 5.26 g / 1 l; sodium acetate trihydrate 3.74 g / 1 l; potassium chloride 5.59 g / 1 l; magnesium chloride 2.03 g / 1 l; sodium glycerophosphate hydrate 9.18 g / 1 l; soya bean oil refined + olive oil refined 200 g / 1 l; calcium chloride dihydrate 1.29 g / 1 l; glucose monohydrate 316.25 g / 1 l - combinations - combinations - triomel is indicated for parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.